Nastech News
Most Popular Nastech Story
Top officers out as MDRNA restructures
Struggling from the withdrawal of a key development partner and last week's mid-stage failure of an intranasal obesity therapy, Bothwell, WA-based MDRNA announced today that it will cut 30 percent of... Read more...
Latest Headlines
- August 5, 2008
- February 13, 2008
- November 15, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
